Phenogen Sciences Inc

Phenogen Sciences Inc. is a privately held company based in Charlotte, North Carolina. Established in 2010, Phenogen Sciences is a US division of Australian-based Genetic Technologies Limited. With a team of four employees, the company generates an annual revenue of $20 million. Phenogen Sciences specializes in personalized healthcare solutions through predictive testing and risk assessment tools. Their products are designed to help physicians proactively manage their patients' health. The company's flagship product, geneType, is a clinically validated predictive risk test that combines genetic and clinical data to assess a woman's personal risk of developing breast cancer. This product line has expanded to include risk assessments for other diseases, such as various cancer types, cardiovascular, metabolic, and infectious diseases. Phenogen Sciences leverages its expertise in integrated risk model development to provide comprehensive risk assessment solutions. The company's parent company, Genetic Technologies Limited, has over 20 years of experience in molecular diagnostics and is a recognized pioneer in the application of 'non-coding' DNA. Genetic Technologies Limited holds patents in 24 countries worldwide. For more information about Phenogen Sciences and their products, visit their website at phenogensciences.com.